Medium Chain Triglycerides (MCTs) for Alzheimers Disease: Benefits for APOE e4(-) Patients?
Alzheimer’s disease (AD) is a growing global health concern, but current drug therapies have shown limited effectiveness for symptom management and disease modification. Medium chain triglycerides (MCTs) have emerged as a potential nutritional therapy, but evi…
Read article